Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Maternal Body Composition and Gestational Weight Gain in Relation to Asthma Control During Pregnancy

Go back to Resources

Maternal Body Composition and Gestational Weight Gain in Relation to Asthma Control During Pregnancy

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E

Go back to Resources

First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study

Go back to Resources

The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.

Go back to Resources

Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects

Go back to Resources

A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

Go back to Resources

Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Transition from On-Site to Remote Site Initiation Activities

Go back to Resources

Transition from On-Site to Remote Site Initiation Activities

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Determining the clinical course of asthma in pregnancy.

Go back to Resources

Determining the clinical course of asthma in pregnancy.

Authors:

Secondary:

Volume:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Design and Implementation of the Site Activation Guidance (SAG) in the National Drug Abuse Treatment Clinical Trials Network (NDAT CTN)

Go back to Resources

Design and Implementation of the Site Activation Guidance (SAG) in the National Drug Abuse Treatment Clinical Trials Network (NDAT CTN)

Authors:

Secondary:

Location:

URL:

Go back to Resources

Neonatal Opioid Withdrawal Syndrome: A Review of the Science and a Look Toward the use of Buprenorphine for Affected Infants

Go back to Resources

Neonatal Opioid Withdrawal Syndrome: A Review of the Science and a Look Toward the use of Buprenorphine for Affected Infants

Authors:

Secondary:

Volume:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions